drugset / Trial / NCT01633099
Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to confirm the safety and the therapeutic effect of Decitabine in the treatment of elderly Acute Myeloid Leukemia (AML) patients.
Timeline
- Start
- 2012-05
- Primary completion
- 2014-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decitabine | Small molecule | 20 mg/m2 | Intravenous |